Could shivering, mild diarrhea, and blood‑pressure changes after consuming 2.8 g of matcha in a patient taking fluvoxamine, risperidone, and topiramate be due to caffeine interaction, and how should it be managed?

Caffeine-Induced Symptoms in a Patient on Fluvoxamine: Likely Drug Interaction

This presentation is most consistent with caffeine toxicity amplified by a significant pharmacokinetic interaction with fluvoxamine, which potently inhibits CYP1A2 and can increase caffeine levels 5-fold. The shivering, diarrhea, and blood pressure changes occurring 2 hours after consuming 2.8g of matcha (containing approximately 200-280mg caffeine) in a patient taking fluvoxamine represent predictable consequences of this interaction 1, 2.

Understanding the Mechanism

Fluvoxamine is a very potent inhibitor of CYP1A2, the primary enzyme responsible for caffeine metabolism 3, 1. This interaction is dose-dependent and clinically significant:

• At therapeutic doses (50-100mg daily), fluvoxamine reduces caffeine clearance by approximately 80-90% 1, 2
• Caffeine half-life increases from 5 hours to 31-56 hours during fluvoxamine treatment 1, 4
• Even low doses of fluvoxamine (10-20mg daily) cause 40-50% inhibition of caffeine metabolism 2

The 2.8g matcha dose contains substantial caffeine that would normally be metabolized within hours, but in this patient on fluvoxamine, caffeine accumulation is dramatically prolonged.

Clinical Presentation Analysis

The symptoms described—shivering, diarrhea, and blood pressure changes—fit a pattern of caffeine toxicity rather than serotonin syndrome, though differentiation requires careful assessment:

Caffeine Toxicity Features (Present):

• Shivering (sympathetic activation)
• Diarrhea (gastrointestinal stimulation)
• Blood pressure changes (cardiovascular effects from catecholamine release)
• Timing: 2 hours post-ingestion aligns with peak caffeine absorption

Serotonin Syndrome Features (Assess for):

While fluvoxamine increases serotonin, and risperidone has weak serotonergic properties, true serotonin syndrome requires additional features 5:

• Mental status changes (confusion, agitation, anxiety)
• Neuromuscular hyperactivity (tremors, clonus, hyperreflexia, muscle rigidity)
• Autonomic hyperactivity (hypertension, tachycardia, diaphoresis)
• Fever (advanced symptom)

Critical distinction: Isolated shivering and diarrhea without neuromuscular hyperactivity (clonus, hyperreflexia, rigidity) or mental status changes makes serotonin syndrome less likely 5.

Immediate Management

1. Discontinue Caffeine Immediately

• No further matcha, coffee, tea, energy drinks, or caffeine-containing products
• Check all medications and supplements for hidden caffeine sources

2. Assess Severity

Monitor for escalating caffeine toxicity 6:

• Vital signs: Heart rate, blood pressure, temperature every 2-4 hours
• Cardiac monitoring: Watch for tachycardia, arrhythmias (caffeine can cause serious dysrhythmias)
• Neurological status: Assess for tremor, agitation, seizures (severe toxicity)
• Gastrointestinal symptoms: Persistent vomiting or severe diarrhea requiring hydration

3. Supportive Care

• Hydration: Oral fluids if tolerating; IV fluids if severe vomiting/diarrhea
• Beta-blockers: Consider if significant tachycardia or hypertension develops (propranolol 10-20mg orally) 6
• Benzodiazepines: For agitation or tremor if present (lorazepam 1-2mg)

4. Rule Out Serotonin Syndrome

Examine specifically for 5:

• Clonus (spontaneous, inducible, or ocular)
• Hyperreflexia (particularly in lower extremities)
• Muscle rigidity
• Hyperthermia (temperature >38°C)

If these features develop: This becomes a medical emergency requiring hospitalization, discontinuation of all serotonergic agents, and aggressive supportive care with continuous cardiac monitoring 5.

Long-Term Management

Patient Education (Critical)

Patients on fluvoxamine must strictly avoid or minimize caffeine 3, 1, 7:

• Caffeine clearance is reduced by 80-90% on fluvoxamine
• Even small amounts (one cup of coffee = 100mg caffeine) can accumulate to toxic levels with daily consumption
• Matcha contains 70-100mg caffeine per gram; this patient consumed approximately 200-280mg in one dose

Dietary Counseling

Avoid or strictly limit:

• Coffee, tea (including green tea/matcha), energy drinks
• Chocolate (contains caffeine and theobromine)
• Caffeine-containing medications (Excedrin, NoDoz, weight loss supplements)
• Pre-workout supplements

Medication Review

Fluvoxamine has extensive drug interactions via CYP1A2, CYP2C19, CYP2C9, CYP3A4, and CYP2D6 inhibition 5, 3:

• Topiramate: No significant interaction expected
• Risperidone: Potential for increased risperidone levels (metabolized partly by CYP2D6); monitor for extrapyramidal symptoms or sedation 8

Common Pitfalls to Avoid

1. Dismissing caffeine as benign: On fluvoxamine, even "normal" caffeine intake becomes dangerous 1, 4, 7

2. Assuming serotonin syndrome without neuromuscular signs: Shivering and diarrhea alone are insufficient for diagnosis; clonus and hyperreflexia are key distinguishing features 5

3. Overlooking hidden caffeine sources: Many supplements, medications, and foods contain caffeine 7

4. Failing to warn patients prospectively: This interaction is predictable and preventable with proper counseling 3, 1

Prognosis and Follow-Up

• Symptoms should resolve within 24-48 hours with caffeine avoidance, given the prolonged half-life
• If symptoms persist beyond 48 hours or worsen, reassess for alternative diagnoses
• Schedule follow-up within 1 week to ensure resolution and reinforce caffeine avoidance
• Document this interaction prominently in the medical record

The key message: This is almost certainly a pharmacokinetic drug interaction between fluvoxamine and caffeine, not serotonin syndrome, and is entirely preventable with proper patient education about strict caffeine avoidance.